Thursday, Jun 1, 2023
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
    • Rewind
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
  • Rewind
Home | Lifestyle | Pioneering Technique May Unlock Targeted Treatments For Cancer Study

Pioneering technique may unlock targeted treatments for cancer: Study

London: Researchers have discovered a pioneering chemical technique that could develop new treatments for cancer and other diseases. The findings of the study were published in the ‘Journal of Medicinal Chemistry’.Members of the Leicester Institute of Structural and Chemical Biology, based at the University of Leicester, used proteolysis targeting chimeras (PROTACs) as a ‘bridge’ to […]

By ANI
Published Date - 09:42 AM, Mon - 21 March 22
Pioneering technique may unlock targeted treatments for cancer: Study
whatsapp facebook twitter telegram

London: Researchers have discovered a pioneering chemical technique that could develop new treatments for cancer and other diseases.

The findings of the study were published in the ‘Journal of Medicinal Chemistry’.Members of the Leicester Institute of Structural and Chemical Biology, based at the University of Leicester, used proteolysis targeting chimeras (PROTACs) as a ‘bridge’ to degrade proteins implicated in cancer.

Scientists can manipulate the effectiveness of treatments by making changes to elements of this PROTAC bridge.

This new study describes how Leicester researchers applied a previously-described protein degradation technique known as PROTACs to degrade histone deacetylation enzymes (HDACs) in a more targeted way than ever before.

HDACs play an important role in gene regulation, in which genes are switched ‘on’ and ‘off’, and are associated with a range of diseases, including cancer as well as various neurodegenerative disorders including Alzheimer’s disease.

Using this pioneering technique to target specific structures within cancerous cells could increase the potency and selectivity of new and existing drugs, meaning patients would require lower systemic exposure to drug treatments leading to a reduction in harmful side-effects to patients.

The group have been granted a patent by the European Patent Office for the pioneering technique.

Dr James Hodgkinson is an Associate Professor in Organic Chemistry and Chemical Biology at the University of Leicester and one of the corresponding authors for the study. He said, “We are really excited about what these new molecules are capable of in cancer cells and their potential future development into medicines.

He added, “Our next steps will involve optimising their chemical structure and biological properties so that one day they could be used to improve the lives of cancer patients.” John Schwabe is Professor of Structural Biology and Director of the Leicester Institute of Structural and Chemical Biology, and also a corresponding author on the study.

Professor Schwabe said, “The potential of using specific degraders of therapeutic targets is very powerful.

“This work has been the result of a productive three-way collaboration between chemists, biologists and biophysicists — an exciting combination to deliver interdisciplinary research,” Professor Schwabe concluded.

  • Follow Us :
  • Tags
  • Cancer
  • Dr James Hodgkinson
  • PROTAC bridge

Related News

  • Alkem launches biosimilar to treat head, neck cancer

    Alkem launches biosimilar to treat head, neck cancer

  • Mulugu: Social activist Sanda Babu fights cancer, needs help

    Mulugu: Social activist Sanda Babu fights cancer, needs help

  • Long-term exposure to diesel pollution bad for health: Experts

    Long-term exposure to diesel pollution bad for health: Experts

  • Researchers find new method that help overcome resistance treatment in cancer

    Researchers find new method that help overcome resistance treatment in cancer

  • Newly-developed censor can detect early signs of cancer, distinguish type of tumours: Study

    Newly-developed censor can detect early signs of cancer, distinguish type of tumours: Study

  • Vitamin D levels may affect body’s response to cancer treatment: Study

    Vitamin D levels may affect body’s response to cancer treatment: Study

Latest News

  • Opinion: Don’t stress over stress

    13 mins ago
  • Editorial: Repairing the relationship

    28 mins ago
  • WTC final: Mohammed Shami has to step up his game, says Ponting

    29 mins ago
  • Disney Star delivers highest-ever ratings for IPL 2023 playoffs

    32 mins ago
  • Indo-Canadian charged with laundering bitcoin worth over $24 mn in US

    53 mins ago
  • Google to shut 3rd-party Notes, Lists integration on Assistant app

    1 hour ago
  • US urges Sudan’s warring sides to return to cease-fire talks, abide by truce

    1 hour ago
  • Hockey: India beat arch-rivals Pakistan 2-1 to emerge Junior Asia Cup champions

    1 hour ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam